Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales.
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic microbiology and infectious disease"
DOI: 10.1016/j.diagmicrobio.2022.115674
Abstract: OBJECTIVE The objective of this study was to evaluate the in vitro activity of aztreonam plus imipenem-relebactam against clinical and isogenic strains of Escherichia coli and Klebsiella pneumoniae co-harboring NDM and >1 serine β-lactamase. METHODS… read more here.
Keywords: relebactam clinical; combination; lactamase; imipenem relebactam ... See more keywords